Cellectar Biosciences, Inc. (CLRB)

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $14.46 million as of January 2, 2026. Its market cap has increased by 35.13% in one year.

• Market Cap: 14.46M
• Enterprise Value: 2.08M
• 1-Year Change: 35.13%
• Ranking: #5072
• Category: Nano-Cap
• Stock Price: $3.41

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $14.46M, an increase of 92.78%. That is a compound annual growth rate of 3.31%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2025	12.50M	1.63%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	9.86%
Dec 31, 2013	21.30M	-37.72%
Dec 31, 2012	34.20M	187.39%
Dec 30, 2011	11.90M	325.00%
Dec 31, 2010	2.80M	-98.80%
Dec 31, 2009	233.20M	2,164.08%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%
Nov 10, 2005	7.50M	-

View and export this data all the way back to 2005. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	962.25B
Johnson & Johnson	498.60B
AbbVie	403.83B
UnitedHealth Group	299.03B
AstraZeneca	287.81B
Novartis AG	266.00B
Merck & Co.	261.26B
Novo Nordisk	227.63B